NRXP NRx Pharmaceuticals, Inc.

2d ago, source: Seeking Alpha

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics based on N-methyl-D-aspartate platform for the treatment of central nervous system disorders ...

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

7d ago, source:

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript

23d ago, source: InvestingChannel on MSN

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript April 1, 2024 NRx Pharmaceuticals, Inc. isn't one of ...

NRx Pharmaceuticals Advances in Breakthrough Bipolar Depression Treatment

11d ago, source: MyChesCo on MSN

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently announced the completion of data collection in its pivotal Phase 2b/3 study ...

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

7d ago, source:

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", "NRx", the "Company"), a clinical-stage biopharmaceutical ...

Investornewsbreaks Nrx Pharmaceuticals Inc. Releases Pricing Of Public Offering, Expected To Result In Estimated $2M

2d ago, source:

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The ...

NRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal Flora

8d ago, source:

NRx Pharmaceuticals, Inc. (NRXP) reported new data that demonstrate that in a rodent model NRX-101 shows no measurable damage to ...

NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

28d ago, source: Finanznachrichten

Common Stock Will Begin Trading on Split-Adjusted Basis on April 2, 2024 RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company ...

NRX Pharmaceuticals Inc Ordinary Shares NRXP

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript

24d ago, source: Seeking Alpha

Good morning everyone and welcome to the NRx Pharmaceuticals, Inc. Fourth Quarter and Full Year 2023 Results Conference Call. [Operator Instructions] As a reminder, this conference call is being ...

NRX Pharmaceuticals Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...